SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology

February 1, 2024

https://www.globenewswire.com/news-release/2024/02/01/2821985/0/en/SeaStar-Medical-Granted-Canadian-Patent-with-Broad-Claims-Covering-the-Selective-Cytopheretic-Device-Technology.html

DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq:ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces the issuance by the Canadian Intellectual Property Office of Canadian Patent No. 2814586. This new patent has broad claims covering the Company’s Selective Cytopheretic Device (SCD) technology. Its issuance expands SeaStar Medical’s international patent rights and complements existing U.S. patent rights.

Read more at globenewswire.com

Related news for (ICU)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.